{"success":true,"data":{"pressRelease":{"id":"161134","rtpr_id":"nPn1trc7Pa-20261005","ticker":"ACB","exchange":"NASDAQ","all_tickers":["ACB"],"title":"Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid","author":"PR Newswire","published_at":"2026-10-05T22:12:16.096Z","article_body":"Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid\nPR Newswire\n\nEDMONTON, AB, Oct. 5, 2026\n\nNASDAQ | TSX: ACB\n\n * Curaleaf has yet to file a Notice of Variation and Change to revise its offer.\nOnce filed, the Special Committee will complete a thorough and comprehensive\nreview prior to issuing a formal recommendation to shareholders\n * Aurora's application to the Alberta Securities Commission delivered results\nfor shareholders: Curaleaf's latest update indicates that Aurora shareholders\nwill be provided with pro forma financials and a bid timeline that complies\nwith securities laws\n * Questions about the Hostile Bid or would like to stay informed? Please contact\nKingsdale Advisors toll-free at 1-800-749-9052 within North America, call or\ntext 416-623-4172 or at\ncontactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com)\n.\nEDMONTON, AB, Oct. 5, 2026 /PRNewswire/ - Aurora Cannabis Inc. (\"Aurora\" or\nthe \"Company\") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global\nmedical cannabis company, responded today to a press release issued by\nCuraleaf Holdings, Inc. (\"Curaleaf\") regarding its stated intention to file a\nNotice of Variation and Change to revise its hostile take-over bid (the\n\"Hostile Bid\") for all of the issued and outstanding common shares of the\nCompany (the \"Aurora Shares\") to offer revised implied consideration of\nUS$5.00 per Share, consisting of 0.4013 subordinate voting shares of Curaleaf\nplus US$1.00 in cash per Aurora Share.\n\nMiguel Martin, Executive Chairman and CEO of Aurora stated, \"Today's\nannouncement by Curaleaf is not a formal revised bid, and Aurora has not yet\nreceived the materials required to conduct a full and proper evaluation. While\nthe announcement suggests an intention to address concerns Aurora identified\nwith Curaleaf's initial Hostile Bid, the Special Committee of independent\ndirectors will review any formal revised offer once received with the same\nrigorous, independent and disciplined process applied previously. The\nCommittee's focus remains on determining what is in the best interests of\nAurora and Aurora shareholders, and the Board will communicate its\nrecommendation once that review is complete.\"\n\nThe Company expects to provide a more comprehensive response to Aurora\nshareholders in a timely manner once the Special Committee has completed its\nreview and the Board has made its recommendation with respect to the revised\nhostile bid.\n\nTake No Action\n\nAurora shareholders are advised to take NO action on the Hostile Bid as\npreviously recommended on September 2, 2026 and wait for further communication\nfrom the Board of Directors . Aurora shareholders will have until at least\nDecember 4, 2026 to consider their options, being the revised expiry date of\nCuraleaf's offer.\n\nThe Board has formed a special committee of independent directors (the\n\"Special Committee\"). The Special Committee will consider the Offer with its\nadvisors before making a recommendation to the Board. Aurora shareholders will\nbe notified of the Board's formal recommendation through a news release and\nDirectors' Circular within 15 days, in accordance with applicable securities\nlaws.\n\nAurora's Application to the Alberta Securities Commission Delivers Results\n\nCuraleaf's actions also demonstrate that Aurora's application to the Alberta\nSecurities Commission delivered results for Aurora Shareholders. In\nparticular, Aurora's application identified several deficiencies in Curaleaf's\ncircular that were contrary to the takeover bid rules and deprived\nshareholders of sufficient information and time needed to fully evaluate\nCuraleaf's Hostile Bid, including the following:\n\n * Failure to provide pro forma financial statements that would allow Aurora\nshareholders to understand the financial condition of the combined company if\nthe Hostile Bid were successful; and\n * Failure to hold the Hostile Bid open for the minimum deposit period required\nby securities laws, which allows Aurora shareholders the full amount of time\nrequired by law to consider the Hostile Bid.\nCuraleaf, in response to the concerns raised by Aurora in its application, has\nnow agreed to amend its bid circular both to include the required pro forma\nfinancial statements and to extend the expiry time for the Hostile Bid to\n11:59pm (Mountain Time) on December 4, 2026.\n\nShareholder Assistance\n\nAurora shareholders with questions about the Hostile Bid or who would like to\nstay informed may contact Kingsdale Advisors, the Company's strategic advisor\nand information agent:\n\n * Toll-Free (within North America): 1-800-749-9052\n * Call or Text: 416-623-4172\n * Email:\ncontactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com)\n * Visit\nprotectaurora.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=1290026416&u=http%3A%2F%2Fwww.protectaurora.com%2F&a=protectaurora.com)\nShareholders should take NO action at this time. Shareholders should wait\nuntil the Board has provided its formal recommendation regarding the Hostile\nBid.\n\nAbout Aurora Cannabis\n\nAurora is a global leader in medical cannabis, dedicated to improving lives\nthrough scientific expertise, proven performance, and a deep commitment to\npatient care. Aurora serves medical markets across Canada, Europe, Australia,\nand New Zealand with a portfolio of trusted, leading brands including\nAurora(®), MedReleaf(®), Pedanios(®), IndiMed™, San Raf(®), and\nWhistler Medical Marijuana Corporation(®). With world-class GMP-certified\nmanufacturing facilities in Canada and Germany, and a team of industry-leading\nprofessionals, Aurora continues to expand its global footprint and deliver\nconsistent, high-quality cannabis products with the purpose of Opening the\nWorld to Cannabis™.\n\nLearn more at www.auroramj.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=1363590381&u=http%3A%2F%2Fwww.auroramj.com%2F&a=www.auroramj.com)\n and follow us on X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3397972197&u=https%3A%2F%2Fx.com%2FAurora_MMJ&a=X)\n and LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3369062363&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faurora-cannabis-inc-%2Fposts%2F&a=LinkedIn)\n.\n\nAurora's common shares trade on the NASDAQ and TSX under the symbol \"ACB\".\n\nAurora has filed a Solicitation/Recommendation Statement on Schedule 14D-9F\nwith the U.S. Securities and Exchange Commission (the \"SEC\"), which includes a\nDirector's Circular, dated September 1, 2026. Investors are urged to read this\ndocument and any other relevant documents filed with the SEC, as well as any\namendments or supplements to these documents, when they become available,\nbefore making any investment decision with respect to the Hostile Bid. The\nHostile Bid is made for the securities of a Canadian issuer and while the\nHostile Bid is subject to disclosure requirements of Canada, investors should\nbe aware that these requirements are different from those of the United\nStates. The enforcement by investors of civil liabilities under the U.S.\nfederal securities laws may be affected adversely by the fact that the issuer\nis located in Canada, and that some or all of its officers and directors are\nresidents of Canada.\n\nForward Looking Statements\n\nThis news release includes statements containing certain \"forward-looking\ninformation\" within the meaning of applicable securities laws\n(\"forward-looking statements\"). Forward-looking statements are frequently\ncharacterized by words such as \"plan\", \"continue\", \"expect\", \"project\",\n\"intend\", \"believe\", \"anticipate\", \"estimate\", \"may\", \"will\", \"potential\",\n\"proposed\" and other similar words, or statements that certain events or\nconditions \"may\" or \"will\" occur. Forward-looking statements made in this news\nrelease include, but are not limited to, statements and information about\nCuraleaf's revised Hostile Bid, including the revised consideration, the\nSpecial Committee's planned review of the revised Hostile Bid and any\nrecommendation with respect to the same.\n\nThese forward-looking statements are only predictions. Forward-looking\ninformation or statements contained in this news release have been developed\nbased on the Company and its management's good faith assumptions relating to\nthe financial, market, regulatory and other relevant environments that will\nexist and affect the Company's business and operations in the future.\nForward-looking information and statements are not a guarantee of future\nperformance and are based upon a number of estimates and assumptions of\nmanagement at the date the statements are made including, among other things,\nassumptions about: development costs remaining consistent with budgets; the\nability to manage anticipated and unanticipated costs; access to favorable\nequity and debt capital markets; the ability to raise sufficient capital to\nadvance the business of the Company; favorable operating and economic\nconditions; political and regulatory stability; obtaining and maintaining all\nrequired licenses and permits; receipt of governmental approvals and permits;\nsustained labour stability; stability in financial and capital goods markets;\nfavorable production levels and costs from the Company's operations; the\npricing of various cannabis products; the level of demand for cannabis\nproducts; the availability of third-party service providers and other inputs\nfor the Company's operations; and the Company's ability to conduct operations\nin a safe, efficient, and effective manner. The Company does not give any\nassurance that the assumptions on which forward-looking information or\nstatements are based will prove to be correct, or that the Company's business\nor operations will not be affected in any material manner by these or other\nfactors not foreseen or foreseeable by the Company or management or beyond the\nCompany's control. Such forward-looking statements are estimates reflecting\nthe Company's best judgment based upon current information and involve a\nnumber of risks and uncertainties, and there can be no assurance that other\nfactors will not affect the accuracy of such forward-looking statements. These\nrisks include, but are not limited to, the ability to retain key personnel,\nthe ability to continue investing in infrastructure to support growth, the\nability to obtain financing on acceptable terms, the continued quality of our\nproducts, customer experience and retention, the development of third party\ngovernment and non-government consumer sales channels, management's estimates\nof consumer demand in Canada and in jurisdictions where the Company exports,\nexpectations of future results and expenses, the availability of additional\ncapital to complete construction projects and facilities improvements, the\nrisk of successful integration of acquired business and operations,\nmanagement's estimation that SG&A will grow only in proportion to revenue\ngrowth, the ability to expand and maintain distribution capabilities, the\nimpact of competition, the general impact of financial market conditions, the\nyield from cannabis growing operations, product demand, changes in prices of\nrequired commodities, competition, and the possibility for changes in laws,\nrules, and regulations in the industry, epidemics, pandemics or other public\nhealth crisis, and other risks as set out under the heading \"Risk Factors\" in\nthe Company's annual information form dated June 10, 2026 (the \"AIF\") and\nfiled with Canadian securities regulators available on the Company's issuer\nprofile on SEDAR+ at www.sedarplus.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3644893692&u=http%3A%2F%2Fwww.sedarplus.com%2F&a=www.sedarplus.com)\n and filed with and available on the SEC's website at www.sec.gov\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3588893752&u=http%3A%2F%2Fwww.sec.gov%2F&a=www.sec.gov)\n. The Company cautions that the list of risks, uncertainties and other factors\ndescribed in the AIF is not exhaustive and other factors could also adversely\naffect its results. Readers are urged to consider the risks, uncertainties and\nassumptions carefully in evaluating the forward-looking statements and are\ncautioned not to place undue reliance on such information. The Company is\nunder no obligation, and expressly disclaims any intention or obligation, to\nupdate or revise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as expressly required by\napplicable securities laws.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/aurora-maintains-shareholder-recommendation-to-take-no-action-at-this-time-as-curaleaf-has-yet-to-file-their-revised-hostile-bid-302898989.html\n(https://www.prnewswire.com/news-releases/aurora-maintains-shareholder-recommendation-to-take-no-action-at-this-time-as-curaleaf-has-yet-to-file-their-revised-hostile-bid-302898989.html)\n\nSOURCE Aurora Cannabis Inc.\n\n\n\nFor Media: Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors:ICR, Inc., Investor Relations, aurora@icrinc.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1136461/Aurora-Cannabis-Inc-Aurora-Maintains-Shareholder-Recommendation.jpg?id=OA2988454\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn1trc7Pa-20261005","title":"Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid","author":"PR Newswire","ticker":"ACB","created":"2026-10-05T22:12:16.096Z","tickers":["ACB"],"exchange":"NASDAQ","article_body":"Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid\nPR Newswire\n\nEDMONTON, AB, Oct. 5, 2026\n\nNASDAQ | TSX: ACB\n\n * Curaleaf has yet to file a Notice of Variation and Change to revise its offer.\nOnce filed, the Special Committee will complete a thorough and comprehensive\nreview prior to issuing a formal recommendation to shareholders\n * Aurora's application to the Alberta Securities Commission delivered results\nfor shareholders: Curaleaf's latest update indicates that Aurora shareholders\nwill be provided with pro forma financials and a bid timeline that complies\nwith securities laws\n * Questions about the Hostile Bid or would like to stay informed? Please contact\nKingsdale Advisors toll-free at 1-800-749-9052 within North America, call or\ntext 416-623-4172 or at\ncontactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com)\n.\nEDMONTON, AB, Oct. 5, 2026 /PRNewswire/ - Aurora Cannabis Inc. (\"Aurora\" or\nthe \"Company\") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global\nmedical cannabis company, responded today to a press release issued by\nCuraleaf Holdings, Inc. (\"Curaleaf\") regarding its stated intention to file a\nNotice of Variation and Change to revise its hostile take-over bid (the\n\"Hostile Bid\") for all of the issued and outstanding common shares of the\nCompany (the \"Aurora Shares\") to offer revised implied consideration of\nUS$5.00 per Share, consisting of 0.4013 subordinate voting shares of Curaleaf\nplus US$1.00 in cash per Aurora Share.\n\nMiguel Martin, Executive Chairman and CEO of Aurora stated, \"Today's\nannouncement by Curaleaf is not a formal revised bid, and Aurora has not yet\nreceived the materials required to conduct a full and proper evaluation. While\nthe announcement suggests an intention to address concerns Aurora identified\nwith Curaleaf's initial Hostile Bid, the Special Committee of independent\ndirectors will review any formal revised offer once received with the same\nrigorous, independent and disciplined process applied previously. The\nCommittee's focus remains on determining what is in the best interests of\nAurora and Aurora shareholders, and the Board will communicate its\nrecommendation once that review is complete.\"\n\nThe Company expects to provide a more comprehensive response to Aurora\nshareholders in a timely manner once the Special Committee has completed its\nreview and the Board has made its recommendation with respect to the revised\nhostile bid.\n\nTake No Action\n\nAurora shareholders are advised to take NO action on the Hostile Bid as\npreviously recommended on September 2, 2026 and wait for further communication\nfrom the Board of Directors . Aurora shareholders will have until at least\nDecember 4, 2026 to consider their options, being the revised expiry date of\nCuraleaf's offer.\n\nThe Board has formed a special committee of independent directors (the\n\"Special Committee\"). The Special Committee will consider the Offer with its\nadvisors before making a recommendation to the Board. Aurora shareholders will\nbe notified of the Board's formal recommendation through a news release and\nDirectors' Circular within 15 days, in accordance with applicable securities\nlaws.\n\nAurora's Application to the Alberta Securities Commission Delivers Results\n\nCuraleaf's actions also demonstrate that Aurora's application to the Alberta\nSecurities Commission delivered results for Aurora Shareholders. In\nparticular, Aurora's application identified several deficiencies in Curaleaf's\ncircular that were contrary to the takeover bid rules and deprived\nshareholders of sufficient information and time needed to fully evaluate\nCuraleaf's Hostile Bid, including the following:\n\n * Failure to provide pro forma financial statements that would allow Aurora\nshareholders to understand the financial condition of the combined company if\nthe Hostile Bid were successful; and\n * Failure to hold the Hostile Bid open for the minimum deposit period required\nby securities laws, which allows Aurora shareholders the full amount of time\nrequired by law to consider the Hostile Bid.\nCuraleaf, in response to the concerns raised by Aurora in its application, has\nnow agreed to amend its bid circular both to include the required pro forma\nfinancial statements and to extend the expiry time for the Hostile Bid to\n11:59pm (Mountain Time) on December 4, 2026.\n\nShareholder Assistance\n\nAurora shareholders with questions about the Hostile Bid or who would like to\nstay informed may contact Kingsdale Advisors, the Company's strategic advisor\nand information agent:\n\n * Toll-Free (within North America): 1-800-749-9052\n * Call or Text: 416-623-4172\n * Email:\ncontactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com)\n * Visit\nprotectaurora.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=1290026416&u=http%3A%2F%2Fwww.protectaurora.com%2F&a=protectaurora.com)\nShareholders should take NO action at this time. Shareholders should wait\nuntil the Board has provided its formal recommendation regarding the Hostile\nBid.\n\nAbout Aurora Cannabis\n\nAurora is a global leader in medical cannabis, dedicated to improving lives\nthrough scientific expertise, proven performance, and a deep commitment to\npatient care. Aurora serves medical markets across Canada, Europe, Australia,\nand New Zealand with a portfolio of trusted, leading brands including\nAurora(®), MedReleaf(®), Pedanios(®), IndiMed™, San Raf(®), and\nWhistler Medical Marijuana Corporation(®). With world-class GMP-certified\nmanufacturing facilities in Canada and Germany, and a team of industry-leading\nprofessionals, Aurora continues to expand its global footprint and deliver\nconsistent, high-quality cannabis products with the purpose of Opening the\nWorld to Cannabis™.\n\nLearn more at www.auroramj.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=1363590381&u=http%3A%2F%2Fwww.auroramj.com%2F&a=www.auroramj.com)\n and follow us on X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3397972197&u=https%3A%2F%2Fx.com%2FAurora_MMJ&a=X)\n and LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3369062363&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faurora-cannabis-inc-%2Fposts%2F&a=LinkedIn)\n.\n\nAurora's common shares trade on the NASDAQ and TSX under the symbol \"ACB\".\n\nAurora has filed a Solicitation/Recommendation Statement on Schedule 14D-9F\nwith the U.S. Securities and Exchange Commission (the \"SEC\"), which includes a\nDirector's Circular, dated September 1, 2026. Investors are urged to read this\ndocument and any other relevant documents filed with the SEC, as well as any\namendments or supplements to these documents, when they become available,\nbefore making any investment decision with respect to the Hostile Bid. The\nHostile Bid is made for the securities of a Canadian issuer and while the\nHostile Bid is subject to disclosure requirements of Canada, investors should\nbe aware that these requirements are different from those of the United\nStates. The enforcement by investors of civil liabilities under the U.S.\nfederal securities laws may be affected adversely by the fact that the issuer\nis located in Canada, and that some or all of its officers and directors are\nresidents of Canada.\n\nForward Looking Statements\n\nThis news release includes statements containing certain \"forward-looking\ninformation\" within the meaning of applicable securities laws\n(\"forward-looking statements\"). Forward-looking statements are frequently\ncharacterized by words such as \"plan\", \"continue\", \"expect\", \"project\",\n\"intend\", \"believe\", \"anticipate\", \"estimate\", \"may\", \"will\", \"potential\",\n\"proposed\" and other similar words, or statements that certain events or\nconditions \"may\" or \"will\" occur. Forward-looking statements made in this news\nrelease include, but are not limited to, statements and information about\nCuraleaf's revised Hostile Bid, including the revised consideration, the\nSpecial Committee's planned review of the revised Hostile Bid and any\nrecommendation with respect to the same.\n\nThese forward-looking statements are only predictions. Forward-looking\ninformation or statements contained in this news release have been developed\nbased on the Company and its management's good faith assumptions relating to\nthe financial, market, regulatory and other relevant environments that will\nexist and affect the Company's business and operations in the future.\nForward-looking information and statements are not a guarantee of future\nperformance and are based upon a number of estimates and assumptions of\nmanagement at the date the statements are made including, among other things,\nassumptions about: development costs remaining consistent with budgets; the\nability to manage anticipated and unanticipated costs; access to favorable\nequity and debt capital markets; the ability to raise sufficient capital to\nadvance the business of the Company; favorable operating and economic\nconditions; political and regulatory stability; obtaining and maintaining all\nrequired licenses and permits; receipt of governmental approvals and permits;\nsustained labour stability; stability in financial and capital goods markets;\nfavorable production levels and costs from the Company's operations; the\npricing of various cannabis products; the level of demand for cannabis\nproducts; the availability of third-party service providers and other inputs\nfor the Company's operations; and the Company's ability to conduct operations\nin a safe, efficient, and effective manner. The Company does not give any\nassurance that the assumptions on which forward-looking information or\nstatements are based will prove to be correct, or that the Company's business\nor operations will not be affected in any material manner by these or other\nfactors not foreseen or foreseeable by the Company or management or beyond the\nCompany's control. Such forward-looking statements are estimates reflecting\nthe Company's best judgment based upon current information and involve a\nnumber of risks and uncertainties, and there can be no assurance that other\nfactors will not affect the accuracy of such forward-looking statements. These\nrisks include, but are not limited to, the ability to retain key personnel,\nthe ability to continue investing in infrastructure to support growth, the\nability to obtain financing on acceptable terms, the continued quality of our\nproducts, customer experience and retention, the development of third party\ngovernment and non-government consumer sales channels, management's estimates\nof consumer demand in Canada and in jurisdictions where the Company exports,\nexpectations of future results and expenses, the availability of additional\ncapital to complete construction projects and facilities improvements, the\nrisk of successful integration of acquired business and operations,\nmanagement's estimation that SG&A will grow only in proportion to revenue\ngrowth, the ability to expand and maintain distribution capabilities, the\nimpact of competition, the general impact of financial market conditions, the\nyield from cannabis growing operations, product demand, changes in prices of\nrequired commodities, competition, and the possibility for changes in laws,\nrules, and regulations in the industry, epidemics, pandemics or other public\nhealth crisis, and other risks as set out under the heading \"Risk Factors\" in\nthe Company's annual information form dated June 10, 2026 (the \"AIF\") and\nfiled with Canadian securities regulators available on the Company's issuer\nprofile on SEDAR+ at www.sedarplus.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3644893692&u=http%3A%2F%2Fwww.sedarplus.com%2F&a=www.sedarplus.com)\n and filed with and available on the SEC's website at www.sec.gov\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4790076-1&h=3588893752&u=http%3A%2F%2Fwww.sec.gov%2F&a=www.sec.gov)\n. The Company cautions that the list of risks, uncertainties and other factors\ndescribed in the AIF is not exhaustive and other factors could also adversely\naffect its results. Readers are urged to consider the risks, uncertainties and\nassumptions carefully in evaluating the forward-looking statements and are\ncautioned not to place undue reliance on such information. The Company is\nunder no obligation, and expressly disclaims any intention or obligation, to\nupdate or revise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as expressly required by\napplicable securities laws.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/aurora-maintains-shareholder-recommendation-to-take-no-action-at-this-time-as-curaleaf-has-yet-to-file-their-revised-hostile-bid-302898989.html\n(https://www.prnewswire.com/news-releases/aurora-maintains-shareholder-recommendation-to-take-no-action-at-this-time-as-curaleaf-has-yet-to-file-their-revised-hostile-bid-302898989.html)\n\nSOURCE Aurora Cannabis Inc.\n\n\n\nFor Media: Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors:ICR, Inc., Investor Relations, aurora@icrinc.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1136461/Aurora-Cannabis-Inc-Aurora-Maintains-Shareholder-Recommendation.jpg?id=OA2988454\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-05T22:12:16.14816789Z","server_sent_at_ms":1791238336148},"received_at":"2026-10-05T22:12:16.198Z","source_url":"https://www.prnewswire.com/news-releases/aurora-maintains-shareholder-recommendation-to-take-no-action-at-this-time-as-curaleaf-has-yet-to-file-their-revised-hostile-bid-302898989.html"},"analysis":{"id":"149678","press_release_id":"161134","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":["live hostile takeover bid creates extended deal uncertainty pending formal revised offer","Curaleaf's initial circular was found deficient under takeover bid rules"],"eventType":"m_and_a","narrative":"Aurora Cannabis reaffirmed its advice that shareholders take no action on Curaleaf's hostile takeover bid, noting Curaleaf has yet to formally file a revised offer.\n\nCuraleaf announced its intention to revise the bid to US$5.00 per Aurora share — 0.4013 subordinate voting shares plus US$1.00 cash — and extended the offer expiry to December 4, 2026.\n\nAurora also claimed victory at the Alberta Securities Commission: Curaleaf agreed to add pro forma financials to its circular and extend the bid period, addressing deficiencies Aurora identified.\n\nThe Special Committee of independent directors will issue its formal recommendation via a Directors' Circular within 15 days of receiving the revised bid materials.","sentiment":"neutral","agentHooks":{"shouldPost":true,"suggestedAngle":"Curaleaf ups hostile bid to US$5.00/share but hasn't filed it — Aurora buys time with ASC win and tells holders to wait."},"keyFigures":{"dealValueUsd":"US$5.00 per share","customDimensions":{"exchange_ratio":0.4013,"revised_bid_expiry":"December 4, 2026, 11:59pm MT","cash_component_per_share_usd":1,"board_recommendation_due_within_days":15}},"quotedText":"Today's announcement by Curaleaf is not a formal revised bid, and Aurora has not yet received the materials required to conduct a full and proper evaluation.","namedEntities":{"people":[{"name":"Miguel Martin","role":"Executive Chairman and CEO of Aurora"},{"name":"Michelle Lefler","role":"VP, Communications & PR"}],"products":["Aurora","MedReleaf","Pedanios","IndiMed","San Raf","Whistler Medical Marijuana Corporation"],"companies":[{"name":"Aurora Cannabis Inc.","ticker":"ACB","relationship":"filer/target of hostile bid"},{"name":"Curaleaf Holdings, Inc.","relationship":"hostile acquirer"},{"name":"Kingsdale Advisors","relationship":"information agent and strategic advisor"},{"name":"Alberta Securities Commission","relationship":"securities regulator"},{"name":"ICR, Inc.","relationship":"investor relations"}],"dollarAmounts":[{"amount":"US$5.00 per Share","context":"revised implied hostile bid consideration"},{"amount":"US$1.00","context":"cash component per Aurora share"}]},"materialImpact":{"score":3,"reasoning":"Curaleaf signaled a revised hostile bid consideration of US$5.00 per Aurora share (0.4013 Curaleaf shares + US$1.00 cash) but has not yet formally filed; Aurora's Special Committee will review and recommends shareholders take no action. Live M&A overhang with material valuation implications, but no new formal offer or decision yet."},"tickerRelevance":{"others":[],"primary":"ACB"},"globalImportance":45,"audienceRelevance":40,"eventTypeSecondary":["legal_litigation"],"importanceComponents":{"tickerTier":"mid-cap with strong retail following","eventGravity":"hostile bid revision signal without formal filing","sectorWeight":"cannabis sector M&A","retailFavoriteBoost":true}},"event_type":"m_and_a","event_type_secondary":["legal_litigation"],"sentiment":"neutral","material_impact_score":3,"narrative":"Aurora Cannabis reaffirmed its advice that shareholders take no action on Curaleaf's hostile takeover bid, noting Curaleaf has yet to formally file a revised offer.\n\nCuraleaf announced its intention to revise the bid to US$5.00 per Aurora share — 0.4013 subordinate voting shares plus US$1.00 cash — and extended the offer expiry to December 4, 2026.\n\nAurora also claimed victory at the Alberta Securities Commission: Curaleaf agreed to add pro forma financials to its circular and extend the bid period, addressing deficiencies Aurora identified.\n\nThe Special Committee of independent directors will issue its formal recommendation via a Directors' Circular within 15 days of receiving the revised bid materials.","key_figures":{"dealValueUsd":"US$5.00 per share","customDimensions":{"exchange_ratio":0.4013,"revised_bid_expiry":"December 4, 2026, 11:59pm MT","cash_component_per_share_usd":1,"board_recommendation_due_within_days":15}},"named_entities":{"people":[{"name":"Miguel Martin","role":"Executive Chairman and CEO of Aurora"},{"name":"Michelle Lefler","role":"VP, Communications & PR"}],"products":["Aurora","MedReleaf","Pedanios","IndiMed","San Raf","Whistler Medical Marijuana Corporation"],"companies":[{"name":"Aurora Cannabis Inc.","ticker":"ACB","relationship":"filer/target of hostile bid"},{"name":"Curaleaf Holdings, Inc.","relationship":"hostile acquirer"},{"name":"Kingsdale Advisors","relationship":"information agent and strategic advisor"},{"name":"Alberta Securities Commission","relationship":"securities regulator"},{"name":"ICR, Inc.","relationship":"investor relations"}],"dollarAmounts":[{"amount":"US$5.00 per Share","context":"revised implied hostile bid consideration"},{"amount":"US$1.00","context":"cash component per Aurora share"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-05T22:12:22.978Z","global_importance":45,"audience_relevance":40,"importance_components":{"tickerTier":"mid-cap with strong retail following","eventGravity":"hostile bid revision signal without formal filing","sectorWeight":"cannabis sector M&A","retailFavoriteBoost":true}},"durationMs":6762,"modelName":"glm-5.3-flashx"}}